Related references
Note: Only part of the references are listed.Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis
Christoph Schramm et al.
JOURNAL OF HEPATOLOGY (2014)
Prevalence of psychiatric disorders and suicidal ideation in liver transplanted patients: A cross-sectional study
Luca Errichiello et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Review article: prescribing medications in patients with cirrhosis a practical guide
J. H. Lewis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Early Treatment of Depressive Symptoms and Long-Term Survival After Liver Transplantation
S. S. Rogal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: Recommendations for patient information
Anthony J. Barron et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Depression, antidepressants, and long-term mortality in heart failure
Crisanto Diez-Quevedo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease
Nagy A. Youssef et al.
LIVER INTERNATIONAL (2013)
Long-Term Quality of Life for Transplant Recipients
Patrizia Burra et al.
LIVER TRANSPLANTATION (2013)
Mental Health Affects the Quality of Life and Recovery After Liver Transplantation
Lisa Renee Miller et al.
LIVER TRANSPLANTATION (2013)
Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients
Silvia Nardelli et al.
METABOLIC BRAIN DISEASE (2013)
Association of Chronic Liver Disease with Depression: A Population-Based Study
Keanu Lee et al.
PSYCHOSOMATICS (2013)
Liver Injury Associated with Antidepressants
Susie H. Park et al.
CURRENT DRUG SAFETY (2013)
Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis
Carmen C. Franz et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Symptomatic Treatment of Interferon-α-Induced Depression in Hepatitis C A Systematic Review
Sara Baraldi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Martin Schaefer et al.
JOURNAL OF HEPATOLOGY (2012)
Reduction in Corticosteroids Is Associated with Better Health-Related Quality of Life after Liver Transplantation
Victor Zaydfudim et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
V. P. B. Grover et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
5-HT2B receptors are required for serotonin-selective antidepressant actions
S. L. Diaz et al.
MOLECULAR PSYCHIATRY (2012)
Distressing Adverse Events After Antidepressant Switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial: Influence of Adverse Events During Initial Treatment with Citalopram on Development of Subsequent Adverse Events with an Alternative Antidepressant
Aaron J. Katz et al.
PHARMACOTHERAPY (2012)
Early Trajectories of Depressive Symptoms after Liver Transplantation for Alcoholic Liver Disease Predicts Long-Term Survival
A. DiMartini et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study
Emmanuelle Corruble et al.
BMC PSYCHIATRY (2011)
Activation of Serotonin Receptor-2B Rescues Small-for-Size Liver Graft Failure in Mice
Yinghua Tian et al.
HEPATOLOGY (2011)
Depressive symptoms predict long-term mortality after liver transplantation
Emmanuelle Corruble et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2011)
Pretransplant Depression, Antidepressant Use, and Outcomes of Orthotopic Liver Transplantation
Shari S. Rogal et al.
LIVER TRANSPLANTATION (2011)
Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
Mohammad R. Ebrahimkhani et al.
NATURE MEDICINE (2011)
Glucocorticoids, cytokines and brain abnormalities in depression
Patricia A. Zunszain et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Depression in Patients with Nonalcoholic Fatty Liver Disease and Chronic Viral Hepatitis B and C
Ali A. Weinstein et al.
PSYCHOSOMATICS (2011)
Quality of Life in Medically Ill Persons with Comorbid Mental Disorders: A Systematic Review and Meta-Analysis
Harald Baumeister et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2011)
Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network
R. Vuppalanchi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Evaluation of Depression as a Risk Factor for Treatment Failure in Chronic Hepatitis C
Peter Derek Christian Leutscher et al.
HEPATOLOGY (2010)
Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection
Andrew J. Muir et al.
HEPATOLOGY (2010)
Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms
Chittaranjan Andrade et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Orbitofrontal volume reductions during emotion recognition in patients with major depression
Johanna Scheuerecker et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2010)
Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease Implications for Dose Adaptation
Chantal Schlatter et al.
DRUG SAFETY (2009)
Sexual Dysfunction After Liver Transplantation
Patrizia Burra
LIVER TRANSPLANTATION (2009)
Psychiatric Care of Patients Undergoing Organ Transplantation
Owen S. Surman et al.
TRANSPLANTATION (2009)
Pretransplant Predictors of Posttransplant Adherence and Clinical Outcome: An Evidence Base for Pretransplant Psychosocial Screening
Fabienne Dobbels et al.
TRANSPLANTATION (2009)
Fulminant Hepatic Failure Induced by Venlafaxine and Trazodone Therapy: A Case Report
O. Detry et al.
TRANSPLANTATION PROCEEDINGS (2009)
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
Roger K. Verbeeck
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a
Patrick Marcellin et al.
LIVER INTERNATIONAL (2008)
Predictors of Relapse to Alcohol and Illicit Drugs After Liver Transplantation for Alcoholic Liver Disease
Roberto Gedaly et al.
TRANSPLANTATION (2008)
Therapy of interferon-induced depression in chronic hepatitis C with citalopram:: a randomised, double-blind, placebo-controlled study
M. R. Kraus et al.
GUT (2008)
Selective serotonin reuptake inhibitors in the context of hepatitis C infection: Reexamining the risks of bleeding
Kari A. Martin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Understanding the health impact of alcohol dependence
Thomas Cargiulo
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis
Erik van Os et al.
JOURNAL OF HEPATOLOGY (2007)
Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases
Martin Haerter et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2007)
Depression, anxiety, and nonalcoholic steatohepatitis
Jill E. Elwing et al.
PSYCHOSOMATIC MEDICINE (2006)
Predictors of relapse to harmful alcohol after orthotopic liver transplantation
M Kelly et al.
ALCOHOL AND ALCOHOLISM (2006)
The pharmacokinetics of escitalopram in patients with hepatic impairment
J Areberg et al.
AAPS JOURNAL (2006)
Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors
J Golden et al.
GENERAL HOSPITAL PSYCHIATRY (2005)
Psychological status and depression in patients with liver cirrhosis
G Bianchi et al.
DIGESTIVE AND LIVER DISEASE (2005)
Evaluation of cingulate gyrus blood flow in patients with liver cirrhosis
M Iwasa et al.
METABOLIC BRAIN DISEASE (2005)
Neuropsychiatric adverse effects of interferon-alpha - Recognition and management
CL Raison et al.
CNS DRUGS (2005)
Dose adjustment in patients with liver disease
F Delco et al.
DRUG SAFETY (2005)
Hepatotoxicity related to citalopram
E López-Torres et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy
Y Nakagawa et al.
ANNALS OF NUCLEAR MEDICINE (2004)
Determinants of Health-Related Quality of Life in Patients With Chronic Liver Diseases
Winfried Haeuser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Treatment of anxiety and depression in transplant patients - Pharmacokinetic considerations
CC Crone et al.
CLINICAL PHARMACOKINETICS (2004)
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
M Schaefer et al.
HEPATOLOGY (2003)
A critical review of selective serotonin reuptake inhibitor-associated bleeding: Balancing the risk of treating hepatitis C-infected patients
RM Weinrieb et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Mirtazapine-induced hepatotoxicity
CK Hui et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Psychiatric disorders among veterans with hepatitis C infection
HB El-Serag et al.
GASTROENTEROLOGY (2002)
Paroxetine for the treatment of interferon-α-induced depression in chronic hepatitis C
MR Kraus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Hepatotoxicity associated with the new antidepressants
AC García-Pando et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
DM Forton et al.
HEPATOLOGY (2002)
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C
P Hauser et al.
MOLECULAR PSYCHIATRY (2002)
Evidence for a cerebral effect of the hepatitis C virus
DM Forton et al.
LANCET (2001)
Lack of citalopram effect on the pharmacokinetics of cyclosporine
HL Liston et al.
PSYCHOSOMATICS (2001)
Neuropsychological characterization of hepatic encephalopathy
K Weissenborn et al.
JOURNAL OF HEPATOLOGY (2001)
Paroxetine for the prevention of depression induced by high-dose interferon alfa
DL Musselman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Depression, fatigue, and functional disability in patients with chronic hepatitis C
MM Dwight et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2000)
Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence
MR DiMatteo et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Clinical pharmacokinetics of mirtazapine
CJ Timmer et al.
CLINICAL PHARMACOKINETICS (2000)
Pharmacokinetics of reboxetine in volunteers with hepatic impairment
A Tran et al.
CLINICAL DRUG INVESTIGATION (2000)
Venlafaxine-associated hepatitis
X Cardona et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
